Elicio Therapeutics to Participate at the Wells Fargo 21st Annual Healthcare Conference

BOSTON, Aug. 24, 2026 (GLOBE NEWSWIRE) -- Elicio Therapeutics, Inc. (Nasdaq: ELTX, “Elicio” or the “Company”), a clinical-stage biotechnology company developing next-generation immunotherapies for KRAS-driven cancers, today announced that management will participate in one-on-one meetings at the upcoming Wells Fargo 21(st) Annual Healthcare Conference, taking place September 8-10, 2026, in Boston, MA.

Wells Fargo 21(st) Annual Healthcare Conference Format: One-on-one Meetings Date: Thursday, September 10, 2026